DeutschNewstral
Article
Mmarketwatch.com on 2016-06-20 13:48
Syros Pharmaceuticals sets IPO price expectations
Related news
- MZentalis Pharmaceuticals sets IPO terms, to be valued at up to $592 millionmarketwatch.com
- MFatburger parent sets IPO price to raise $24 millionmarketwatch.com
Milacron sets price to complete first Cincinnati IPO in yearsbizjournals.com- Rockville biotech sets share price ahead of IPObizjournals.com
- MDocuSign sets IPO terms, with expectations to raise up to $417.5 millionmarketwatch.com
- MADT's stock opens below IPO price, which was already well below expectationsmarketwatch.com
- MPMV Pharmaceuticals prices IPO at top end of expectations, raises $211.8 millionmarketwatch.com
Snapchat company’s IPO surpasses expectationspressherald.com- MSatsuma Pharmaceuticals sets IPO terms to raise up to $80 millionmarketwatch.com
- MDova Pharmaceuticals sets IPO terms to raise $69.1 million before optionsmarketwatch.com
- Apellis adds $35M to IPO cap, sets share price targetbizjournals.com
- Rockville bio sets share price ahead of IPObizjournals.com
AppDynamics Sets Terms for IPOwsj.com- OpGen sets IPO price at $8 to $10 per sharebizjournals.com
- FZoomInfo prices $8bn IPO above expectationsft.com
- MAcacia Communications sets price range for IPO next weekmarketwatch.com
- Pinterest Sets Planned IPO Price Below Last Valuationwsj.com
Instacart sets IPO price at $30 a sharestaradvertiser.com- FRussia’s Fix Price raises IPO expectations as BlackRock and Qatar back floatft.com
- MQuicken Loans parent Rocket Companies stock debuts falls flat, after downsized IPO price below expectationsmarketwatch.com